StrokeFESAPPUENCT03722693
Fesia Functional Electrical Stimulation for Upper Extremity
An observational study of Stroke, run by University of Belgrade at 1 site in Serbia.
Trial summary
Functional electrical stimulation (FES) uses electrical currents to externally activate the nerves and finally activate the muscles responsible for the movements of interest. FES applied via transcutaneous electrodes is a common rehabilitation technique for assisting grasp in patients with central nervous system… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- Functional electrical stimulation based treatment
- Type of treatment
- Medical device
- How many people
- 10 participants
- Where
- 1 siteSerbia
- Study dates
- 22 Jun 2021to 22 Oct 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Subacute stroke subject with initial wrist extension.
Who may be able to join
- stroke confirmed by MRI or CT scan
- time from stroke < 6 months
- age above 18
- able to comply with study protocol
- able to communicate effectively
- able to provide informed consent
- existence of a residual voluntary extension movement either on the wrist or any of the fingers (even if very weak)
- to sit in a position determined for exercises
Who cannot join
- - dependent on care, prior to stroke, for activities of daily living
- severe medical condition in any arm that precludes participation in the study
- previous injury, disease, or contracture affecting paretic or normal arm or hand
- pre-existent neurologic disease or injury
- a metal implant in the affected upper limb
- electrical life support devices
Show all 9Show fewer
- Modified Ashworth > 3
- Finger and wrist Fugl Mayer score = 2
- current participation in another study involving physical rehabilitation of the arm.
Trial locations and contacts
1 site in 1 country.
Serbia1 site
Clinic for rehabilitation dr Miroslav Zotovic Faculty of Medicine University of Belgrade
Belgrade, 11000
About this study
Official title: Comparison of Two Types of Functional Electrical Stimulation Based Treatments for Upper Extremity in Subacute Stroke Patients
Functional electrical stimulation (FES) uses electrical currents to externally activate the nerves and finally activate the muscles responsible for the movements of interest. FES applied via transcutaneous electrodes is a common rehabilitation technique for assisting grasp in patients with central nervous system lesions. In upper extremities, FES can be used as neural-prosthesis, or as a therapeutic tool. In the former, some of the missing functionality is achieved by externally controlled electrical stimulation, wherein the latter FES provides functional exercise which is proven to lead to relearning of motor control, as well as muscle strengthening, thus aiding reestablishment of some of the functionality. Technology that will be used in this study enhances the capacity of FES through the application of multi-pad electrodes and smart protocols for rehabilitation exercises. To improve the stimulation effectiveness of conventional FES, introduced technology relies on spatio-temporal distributed stimulation over the multi-pad electrodes and a battery of predefined, field-tested protocols for rehabilitation.
Read the detailed description
The participants will be split into two balanced groups (randomly assigned), and one of the groups will start with AUTO intervention followed by FUNCTION, and the other group will start with FUNCTION intervention followed by AUTO intervention. The total duration of the study will be 6 months.
Each participant will receive 28 therapy sessions (5 sessions per week approx.) in total, that are divided into four blocks of 7 sessions. During the first 7 sessions the participant will receive standard care treatment (S). This block will be followed by standard care treatment (S) and first FES intervention block with 7 sessions of protocol A (AUTO or FUNCTION). Third block will consider additional 7 sessions of standard care (S). Fourth block will include standard care (S) and 7 sessions of FES intervention with other type of treatment B (FUNCTION or AUTO).
Each of the sessions of FES will have a total duration of 45 minutes. This 45-minute session contains system donning/doffing, adjusting stimulation amplitude (AUTO and FUNCTION), defining VEs for 8 movement primitives (FUNCTION) and exercises.
During assessment sessions the investigator will evaluate the condition of the hand of the participant in different aspects. Clinical scales and data collected from a inertial sensor system will be used.
Clinicians will first of all apply the Modified Ashworth scale to different extensors and flexors of the wrist and fingers in order to determine the spasticity level.
After this they will perform the Fugl Meyer assesment for the upper-limbs to estimate the sensorimotor function of the whole upper-limb (from shoulder to hand).
Then, participants will perform the ARAT test to evaluate the arm and hand function reaching and grasping different types of objects.
Finally, the BEAGLE system will be used for measuring the active and passive ranges of motion of the wrist and fingers.
Anthropometric measures and questionnaire data will be collected. The Visual Analog Scale (VAS) will be filled by the participants, where they will indicate their level of pain before starting the therapy.
The electrode will be attached on the participants forearm always taking the head of ulna as the reference.
The Fesia Walk stimulator will be used in this study. It is a wireless stimulator with a single current source capable of emitting pulses and controlling up to 32 cathode and 8 anode pads independently. It is designed to be controlled remotely via Bluetooth communication. It is connected to the multi-pad electrode by means of a pressure connector, and the connection is secured by means of a rigid plastic socket attached to the electrode. As for battery charging, it is carried out using any generic charger with microUSB connection. The software used at the start of the study will be the NeuroResearch software. This is a multi-platform software developed in html5. It provides means to control the stimulation parameters of the Fesia Walk stimulator as well as creating and saving virtual electrodes (VEs), patterns and functions. It is a versatile software that can be used with different types of multi-field electrodes and it brings the possibility of combining and testing different VEs and patterns to perform several functions. In parallel, an adaptation of this software for its use in clinics is being developed. This new software, called NeuroClinics Grasp, will be designed for its specific use with forearm garments for hand and wrist applications. It will have a simplified user interface and a limited set of configurable parameters to increase its ease of use. This software will be introduced during the study and feedback from therapists will be taken into account to make possible further modifications on it. If the NeuroClinics Grasp software gets ready at any time during the study and therapists think that it might ease the calibration procedures of the study, then, this software will replace the NeuroResearch software. Two different multi-pad electrodes (A and B) will be used during this study. Both were specifically designed for covering the extrinsic muscles of the hand, located on the forearm, and are comprised of 8 anodes and 32 cathodes. Electrode A or B will be used, alternating them over sessions with each participant.
Then the calibration procedure will take place, which will imply defining the virtual electrodes (VE) for each of the 8 movement primitives: wrist extension, wrist flexion, index flexion, index extension, mass finger extension, mass finger flexion, thumb extension and thumb flexion.
A VE is a group of electrode pads which, when stimulated together produce a movement primitive, and in this case it will be configured with two parameters: the selection of pads (cathodes) that should compound the VE and the amplitude (mA) of the VE.
All the anodes will be active for all the VEs except those located closer than 2 cm from the selected pads (cathodes). This anode configuration will be automatic.
In the AUTO case, the pads will be preset for each VE, based on results of previous studies for achieving different movement primitives. So, only the amplitude should be tuned for each VE. This will be done increasing the amplitude in 1mA steps until patient's tolerance or until a full function is achieved, whichever happens first.
Only if there is no movement at all and the therapist considers that it is due to a bad VE pad configuration, then the therapist will be allowed to adapt the best pads for that specific participant during the first therapy session only, but relying only on the knowledge of anatomy and not by trial and error tests of different configurations. Then this VE configuration will be set for the rest of AUTO therapy sessions for that participant.
Once all the amplitudes are defined for each of the VEs or movement primitives, then the FES response questionnaire (attached in the annex) will be filled by the therapist and at the same movements will be recorded with BEAGLE. Testing each of the movement primitives with the configured parameters and classifying the motor response as none, partial or full function.
Then, the therapist will run the AUTO mode, which will consist of cyclic stimulation of the pre-configured VEs. The VEs will be activated in a pseudorandom order in series of 5 repetitions of each movement with 50% duty cycle. Number of series will be calculated based on the remaining time after amplitude calibration and questionnaire filling. The amplitude will start being 10% less than configured and it will end being 10% more than configured to compensate any fatigue that could happen during the sessions. Once the stimulation is finished, the therapist will test each of the movement primitives again (as configured before), fill the FES response questionnaire (attached in the annex) and record movements with BEAGLE, and the participant will fill the VAS scale again. Like this we will be able to check the short-term effect of the therapy in terms of pain and motor response.
During the FUNCTION therapy sessions the therapist will always be able to configure or adapt the VE pads to the participant. Moreover, instead of a pseudo-random stimulation, FES will target those movement primitives that are most impaired in the participant for generating different grasps.
In the FUNCTION case, both the pads and the amplitude should be tuned for each movement primitive and each participant. The first session there will be a pad configuration preset that will serve as a guidance for the therapists, and from then on the configuration for that specific participant will be saved. The amplitude will be set for each VE increasing the amplitude in 1mA steps until participant's tolerance or until a full function is achieved, whichever happens first.
The therapist will be allowed at the beginning of each session to adapt the best pads for that specific participant and movement primitive. This will be done by modifying the number and location of the selected pads until the target movement primitive is achieved. Then this VE configuration will be set for the rest of the session.
Once all the amplitudes and pad configurations are defined for each of the VEs or movement primitives, then the FES response questionnaire (attached in the annex) will be filled by the therapist and at the same time movement will be recorded with BEAGLE. Testing each of the movement primitives with the configured parameters and classifying the motor response as none, partial or full function.
Then, the therapist will run the FUNCTION mode, and she/he will reduce the amplitudes (below motor threshold) of the movement primitives that are part of the participant's residual voluntary movements. Like this we will focus on the movement primitives that are most impaired and we will take advantage of the residual function of the participant. Once these amplitudes are adapted, the FUNCTION mode will be turned on. In a FUNCTION, VEs will be temporally arranged to form demanding hand function (palmar and lateral grasp) or simple task (wrist extension, wrist extension...). Functions will be chosen based on the capabilities and needs of the patient. A therapist will choose individual FUNCTION and number of repetitions.
Duration of the FUNCTION will be calculated based on the remaining time after VEs calibration and questionnaire filling. The amplitude will start being 10% less than configured and it will end being 10% more than configured to compensate any fatigue that could happen during the sessions.
During the FUNCTION mode the participant will be instructed to follow the stimulation patterns to make the grasps and thus, assist the FES with movement intention and residual voluntary contractions. Targeted movement will be shown on the monitor and synchronized with stimulation.
Once the stimulation is finished, the therapist will test each of the movement primitives again (as configured before) and fill the FES response questionnaire, and the participant will fill the VAS scale again. Like this we will be able to check the short-term effect of the therapy in terms of pain and motor response.
- Conditions
- Stroke
- Being tested
- Functional electrical stimulation based treatment
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Functional electrical stimulation based treatmentDevice
Two types of multi-pad electrodes will be used during this study. Both were designed for covering the extrinsic muscles of the hand. Electrodes are comprised of 8 pads that act as anodes and 32 pads that acted as cathodes. The shape and distribution of the conductive pads within the electrodes were designed considering the motor points for achieving different movement primitives (wrist extension, wrist flexion, fingers extension, fingers flexion, index extension, index flexion, thumb extension, and thumb flexion). Each participant will receive 5 assessment sessions:1. before starting the interventions, 2. after the 7 days of standard care, 3. after 7 days of first FES based protocol, 4.after another 7 days of standard care and 5. after seven days of the other FES based intervention
| Study group | Role | What they receive |
|---|---|---|
| Experimental group | Experimental group included subacute stroke patients with initial wrist extension. Each participant will receive 28 therapy sessions in total, that are divided into four blocks of 7 sessions. During the first 7 sessions the participant will receive standard care treatment (S), this block will be followed by first Functional electrical stimulation based treatment (FES intervention) block with 7 sessions of protocol A (AUTO or FUNCTION). Third block will consider additional 7 sessions of standard care (S). Fourth block will include 7 sessions of Functional electrical stimulation based treatment (FES intervention) with other type of treatment B (FUNCTION or AUTO). Receives: Device: Functional electrical stimulation based treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Action research arm test (ARAT test)
Action research arm test (ARAT) measures specific changes in the arm function in individuals who sustained cerebral damage resulting in arm weakness. The ARAT consists of 19 items grouped into four subscales:
: grasp, grip, pinch and gross movements. Each subscale constitutes a hierarchical scale, which means that all items are ordered according to ascending difficulty. The performance of the subjects in each subscale is scored on a four level ordinal scale: 0- can not perform any part of the test, 1- performs the test partialy, 2- completes the test, but takes abnormally long time, 3- performs the test normally. The sum of all subscales are added to compute the total score. The total score ranges between 0 to 57. The higher score is considered to be better outcome.
Measured: once in 10 days
Secondary outcomes (3)
Range of motions of wrist and digits
Estimations in angle degrees
Measured: daily during 28 days
Fugl Mayer motor score for upper extremity
Fugl Meyer motor score for upper extremity assesses the degree of synergistic movements in the paretic upper limb. Individual items pertaining to the shoulder/elbow and hand segments are scored on a 3-point ordinal scale and summed for a maximum possible score of 66. The Fugl Meyer motor score for upper extremity is reported as a total score. The higher score is considered to represent a better performance of the subject.
Measured: once in 10 days
The Modified Ashworth score
The Modified Ashworth scale is a rating scale to measure abnormality in tone or the resistance to passive movements.It is a 6-point ordinal scale. The higher score indicates the higher level of the muscle tone.
Measured: once in 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Oct 2018
- Study start22 Jun 2021
- Primary completion22 May 2023
- Study completion22 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Belgrade
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Konstantinovic Ljubica, University of Belgrade
- Investigators
- Ljubica M Konstantinovic, PhD, Study chair, Clinic for Rehabilitation dr Miroslav Zotovic, Faculty of Medicine University of Belgrade
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03722693
- Sponsor's protocol ID
- UBelgrade
- Acronym
- FESAPPUE
- Status last verified
- Nov 2023
- First submitted
- 3 Oct 2018
- Last updated
- 29 Nov 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Two Types of Functional Electrical Stimulation Based Treatments for Upper Extremity in Subacute Stroke Patients
- ClinicalTrials.gov ID
- NCT03722693
- Acronym / sponsor ID
- FESAPPUE / UBelgrade
- Conditions
- Stroke
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- University of BelgradeUniversity, hospital or other
- Study start
- 22 Jun 2021 (actual)
- Primary completion
- 22 May 2023 (actual)
- Study completion
- 22 Oct 2023 (actual)
- First posted
- 29 Oct 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Functional electrical stimulation (FES) uses electrical currents to externally activate the nerves and finally activate the muscles responsible for the movements of interest. FES applied via transcutaneous electrodes is a common rehabilitation technique for assisting grasp in patients with central nervous system lesions. In upper extremities, FES can be used as neural-prosthesis, or as a therapeutic tool. In the former, some of the missing functionality is achieved by externally controlled electrical stimulation, wherein the latter FES provides functional exercise which is proven to lead to relearning of motor control, as well as muscle strengthening, thus aiding reestablishment of some of the functionality. Technology that will be used in this study enhances the capacity of FES through the application of multi-pad electrodes and smart protocols for rehabilitation exercises. To improve the stimulation effectiveness of conventional FES, introduced technology relies on spatio-temporal distributed stimulation over the multi-pad electrodes and a battery of predefined, field-tested protocols for rehabilitation.
Detailed description
The participants will be split into two balanced groups (randomly assigned), and one of the groups will start with AUTO intervention followed by FUNCTION, and the other group will start with FUNCTION intervention followed by AUTO intervention. The total duration of the study will be 6 months.
Each participant will receive 28 therapy sessions (5 sessions per week approx.) in total, that are divided into four blocks of 7 sessions. During the first 7 sessions the participant will receive standard care treatment (S). This block will be followed by standard care treatment (S) and first FES intervention block with 7 sessions of protocol A (AUTO or FUNCTION). Third block will consider additional 7 sessions of standard care (S). Fourth block will include standard care (S) and 7 sessions of FES intervention with other type of treatment B (FUNCTION or AUTO).
Each of the sessions of FES will have a total duration of 45 minutes. This 45-minute session contains system donning/doffing, adjusting stimulation amplitude (AUTO and FUNCTION), defining VEs for 8 movement primitives (FUNCTION) and exercises.
During assessment sessions the investigator will evaluate the condition of the hand of the participant in different aspects. Clinical scales and data collected from a inertial sensor system will be used.
Clinicians will first of all apply the Modified Ashworth scale to different extensors and flexors of the wrist and fingers in order to determine the spasticity level.
After this they will perform the Fugl Meyer assesment for the upper-limbs to estimate the sensorimotor function of the whole upper-limb (from shoulder to hand).
Then, participants will perform the ARAT test to evaluate the arm and hand function reaching and grasping different types of objects.
Finally, the BEAGLE system will be used for measuring the active and passive ranges of motion of the wrist and fingers.
Anthropometric measures and questionnaire data will be collected. The Visual Analog Scale (VAS) will be filled by the participants, where they will indicate their level of pain before starting the therapy.
The electrode will be attached on the participants forearm always taking the head of ulna as the reference.
The Fesia Walk stimulator will be used in this study. It is a wireless stimulator with a single current source capable of emitting pulses and controlling up to 32 cathode and 8 anode pads independently. It is designed to be controlled remotely via Bluetooth communication. It is connected to the multi-pad electrode by means of a pressure connector, and the connection is secured by means of a rigid plastic socket attached to the electrode. As for battery charging, it is carried out using any generic charger with microUSB connection. The software used at the start of the study will be the NeuroResearch software. This is a multi-platform software developed in html5. It provides means to control the stimulation parameters of the Fesia Walk stimulator as well as creating and saving virtual electrodes (VEs), patterns and functions. It is a versatile software that can be used with different types of multi-field electrodes and it brings the possibility of combining and testing different VEs and patterns to perform several functions. In parallel, an adaptation of this software for its use in clinics is being developed. This new software, called NeuroClinics Grasp, will be designed for its specific use with forearm garments for hand and wrist applications. It will have a simplified user interface and a limited set of configurable parameters to increase its ease of use. This software will be introduced during the study and feedback from therapists will be taken into account to make possible further modifications on it. If the NeuroClinics Grasp software gets ready at any time during the study and therapists think that it might ease the calibration procedures of the study, then, this software will replace the NeuroResearch software. Two different multi-pad electrodes (A and B) will be used during this study. Both were specifically designed for covering the extrinsic muscles of the hand, located on the forearm, and are comprised of 8 anodes and 32 cathodes. Electrode A or B will be used, alternating them over sessions with each participant.
Then the calibration procedure will take place, which will imply defining the virtual electrodes (VE) for each of the 8 movement primitives: wrist extension, wrist flexion, index flexion, index extension, mass finger extension, mass finger flexion, thumb extension and thumb flexion.
A VE is a group of electrode pads which, when stimulated together produce a movement primitive, and in this case it will be configured with two parameters: the selection of pads (cathodes) that should compound the VE and the amplitude (mA) of the VE.
All the anodes will be active for all the VEs except those located closer than 2 cm from the selected pads (cathodes). This anode configuration will be automatic.
In the AUTO case, the pads will be preset for each VE, based on results of previous studies for achieving different movement primitives. So, only the amplitude should be tuned for each VE. This will be done increasing the amplitude in 1mA steps until patient's tolerance or until a full function is achieved, whichever happens first.
Only if there is no movement at all and the therapist considers that it is due to a bad VE pad configuration, then the therapist will be allowed to adapt the best pads for that specific participant during the first therapy session only, but relying only on the knowledge of anatomy and not by trial and error tests of different configurations. Then this VE configuration will be set for the rest of AUTO therapy sessions for that participant.
Once all the amplitudes are defined for each of the VEs or movement primitives, then the FES response questionnaire (attached in the annex) will be filled by the therapist and at the same movements will be recorded with BEAGLE. Testing each of the movement primitives with the configured parameters and classifying the motor response as none, partial or full function.
Then, the therapist will run the AUTO mode, which will consist of cyclic stimulation of the pre-configured VEs. The VEs will be activated in a pseudorandom order in series of 5 repetitions of each movement with 50% duty cycle. Number of series will be calculated based on the remaining time after amplitude calibration and questionnaire filling. The amplitude will start being 10% less than configured and it will end being 10% more than configured to compensate any fatigue that could happen during the sessions. Once the stimulation is finished, the therapist will test each of the movement primitives again (as configured before), fill the FES response questionnaire (attached in the annex) and record movements with BEAGLE, and the participant will fill the VAS scale again. Like this we will be able to check the short-term effect of the therapy in terms of pain and motor response.
During the FUNCTION therapy sessions the therapist will always be able to configure or adapt the VE pads to the participant. Moreover, instead of a pseudo-random stimulation, FES will target those movement primitives that are most impaired in the participant for generating different grasps.
In the FUNCTION case, both the pads and the amplitude should be tuned for each movement primitive and each participant. The first session there will be a pad configuration preset that will serve as a guidance for the therapists, and from then on the configuration for that specific participant will be saved. The amplitude will be set for each VE increasing the amplitude in 1mA steps until participant's tolerance or until a full function is achieved, whichever happens first.
The therapist will be allowed at the beginning of each session to adapt the best pads for that specific participant and movement primitive. This will be done by modifying the number and location of the selected pads until the target movement primitive is achieved. Then this VE configuration will be set for the rest of the session.
Once all the amplitudes and pad configurations are defined for each of the VEs or movement primitives, then the FES response questionnaire (attached in the annex) will be filled by the therapist and at the same time movement will be recorded with BEAGLE. Testing each of the movement primitives with the configured parameters and classifying the motor response as none, partial or full function.
Then, the therapist will run the FUNCTION mode, and she/he will reduce the amplitudes (below motor threshold) of the movement primitives that are part of the participant's residual voluntary movements. Like this we will focus on the movement primitives that are most impaired and we will take advantage of the residual function of the participant. Once these amplitudes are adapted, the FUNCTION mode will be turned on. In a FUNCTION, VEs will be temporally arranged to form demanding hand function (palmar and lateral grasp) or simple task (wrist extension, wrist extension...). Functions will be chosen based on the capabilities and needs of the patient. A therapist will choose individual FUNCTION and number of repetitions.
Duration of the FUNCTION will be calculated based on the remaining time after VEs calibration and questionnaire filling. The amplitude will start being 10% less than configured and it will end being 10% more than configured to compensate any fatigue that could happen during the sessions.
During the FUNCTION mode the participant will be instructed to follow the stimulation patterns to make the grasps and thus, assist the FES with movement intention and residual voluntary contractions. Targeted movement will be shown on the monitor and synchronized with stimulation.
Once the stimulation is finished, the therapist will test each of the movement primitives again (as configured before) and fill the FES response questionnaire, and the participant will fill the VAS scale again. Like this we will be able to check the short-term effect of the therapy in terms of pain and motor response.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experimental group | – | Device: Functional electrical stimulation based treatmentExperimental group included subacute stroke patients with initial wrist extension. Each participant will receive 28 therapy sessions in total, that are divided into four blocks of 7 sessions. During the first 7 sessions the participant will receive standard care treatment (S), this block will be followed by first Functional electrical stimulation based treatment (FES intervention) block with 7 sessions of protocol A (AUTO or FUNCTION). Third block will consider additional 7 sessions of standard care (S). Fourth block will include 7 sessions of Functional electrical stimulation based treatment (FES intervention) with other type of treatment B (FUNCTION or AUTO). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Subacute stroke subject with initial wrist extension.
Key inclusion criteria (8 listed)
- stroke confirmed by MRI or CT scan
- time from stroke < 6 months
- age above 18
- able to comply with study protocol
- able to communicate effectively
Key exclusion criteria (9 listed)
- - dependent on care, prior to stroke, for activities of daily living
- severe medical condition in any arm that precludes participation in the study
- previous injury, disease, or contracture affecting paretic or normal arm or hand
- pre-existent neurologic disease or injury
- a metal implant in the affected upper limb
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Functional electrical stimulation based treatmentTwo types of multi-pad electrodes will be used during this study. Both were designed for covering the extrinsic muscles of the hand. Electrodes are comprised of 8 pads that act as anodes and 32 pads that acted as cathodes. The shape and distribution of the conductive pads within the electrodes were designed considering the motor points for achieving different movement primitives (wrist extension, wrist flexion, fingers extension, fingers flexion, index extension, index flexion, thumb extension, and thumb flexion). Each participant will receive 5 assessment sessions:1. before starting the interventions, 2. after the 7 days of standard care, 3. after 7 days of first FES based protocol, 4.after another 7 days of standard care and 5. after seven days of the other FES based intervention | Device | Experimental group |
Primary outcome
Action research arm test (ARAT test)
Time frame: once in 10 days
Action research arm test (ARAT) measures specific changes in the arm function in individuals who sustained cerebral damage resulting in arm weakness. The ARAT consists of 19 items grouped into four subscales: : grasp, grip, pinch and gross movements. Each subscale constitutes a hierarchical scale, which means that all items are ordered according to ascending difficulty. The performance of the subjects in each subscale is scored on a four level ordinal scale: 0- can not perform any part of the test, 1- performs the test partialy, 2- completes the test, but takes abnormally long time, 3- performs the test normally. The sum of all subscales are added to compute the total score. The total score ranges between 0 to 57. The higher score is considered to be better outcome.
3 secondary outcomes
Range of motions of wrist and digits
Time frame: daily during 28 days
Fugl Mayer motor score for upper extremity
Time frame: once in 10 days
The Modified Ashworth score
Time frame: once in 10 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Nov 2023.
Related trials for Stroke
RecruitingPhase 1/2
Safety and Efficacy of CG-BM1 in Ischemic Stroke
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Not yet recruitingPhase 3
Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence
Acute Ischemic Stroke
Recruiting
Effects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke
Stroke
Recruiting
Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy
Acute Ischemic Stroke
Not yet recruitingObservational study
The GEIR Registry: Rationale and Design of the First Nationwide Multicentre Retinal Stroke Registry in Spain
Retinal Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ljubica M Konstantinovic, PhD study chair
Clinic for Rehabilitation dr Miroslav Zotovic, Faculty of Medicine University of Belgrade
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke, run by University of Belgrade at 1 site in Serbia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Serbia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Action research arm test (ARAT test) (time frame: once in 10 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.